Integrative genomics to define osteocyte differentiation, regulation and function

综合基因组学定义骨细胞分化、调节和功能

基本信息

  • 批准号:
    8909062
  • 负责人:
  • 金额:
    $ 34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-08 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Osteocytes are osteoblast-derived cells that are progressively entombed in mineralized matrix where they function to regulate skeletal homeostasis; their importance is highlighted both by their relative abundance and by their exceptionally long lifespan. Surprisingly, although osteocytes are known to manifest unique gene expression patterns relative to their osteoblast precursors and, as a consequence, display unique form and function, little is known of the molecular mechanisms that orchestrate their transition from the osteoblast or of the epigenomic and regulomic determinants that are responsible. In addition, although Wnt signaling is known to be a major but differential regulator of osteoblast and osteocyte activities, the majority of the gene targets that comprise the cell-specific activities of this pathway and the mechanisms through which TCF/LEF/b-catenin function to modulate these targets in both cell types remain unknown. Accordingly, the objectives of the first two aims are as follows. Aim 1: Identify the underlying epigenomic and regulomic mechanisms and associated molecular determinants that are responsible on a genome-wide scale for the osteoblast to osteocyte transition both in vitro and ex vivo. Aim 2: Examine and contrast the impact of the Wnt signaling pathway on osteoblast- and mature osteocyte-specific gene expression patterns and assess the molecular mechanisms through which these gene subsets are modulated directly by b-catenin and impacted by PTH and 1,25(OH)2D3 both in vitro and ex vivo. Our preliminary data and that of others have shown that a number of genes are upregulated during the osteocyte transition, including Sost, Fgf23, Tnfsf11, and Enpp1/3. The Sost gene, which encodes the Wnt pathway antagonist sclerostin (SCL), is of primary importance, however, due to its central biological actions on bone formation, its impact in disease, and its relevance as a potential therapeutic target. Progress has been made in understanding Sost regulation, prompted in part by the discovery that deletion of a downstream Sost enhancer alters Sost expression and is responsible for Van Buchem disease. Our preliminary data, however, suggest significant additional complexity, thus supporting the final objective of this proposal. Aim 3: Assess the molecular mechanisms that underlie both basal and regulated osteocyte expression of Sost at both epigenomic and regulomic levels in both in vitro and in vivo models. Osteocytes play unique roles in the skeleton and act in endocrine fashion to elaborate both local paracrine factors such as sclerostin and systemically active hormones such as FGF23. Pathologic consequences arising from aberrant osteocyte function can be catastrophic. Detailed basic insights arising from the proposed studies are likely to provide new routes of therapeutic intervention for a multiplicity of diseases that affect the skeleton.
描述(由申请人提供):骨细胞是成骨细胞衍生的细胞,其逐渐埋藏在矿化基质中,在矿化基质中发挥调节骨骼稳态的功能;其重要性因其相对丰度和异常长的寿命而突出。令人惊讶的是,虽然已知骨细胞相对于其成骨细胞前体表现出独特的基因表达模式,并因此显示出独特的形式和功能,但对协调其从成骨细胞转变的分子机制或负责的表观基因组和调节组决定因素知之甚少。此外,尽管Wnt信号传导已知是成骨细胞和骨细胞活性的主要但不同的调节剂,但构成该途径的细胞特异性活性的大多数基因靶点以及TCF/LEF/b-连环蛋白在两种细胞类型中调节这些靶点的机制仍然未知。因此,前两个目标的目标如下。目标1:确定潜在的表观基因组和调节机制和相关的分子决定因素,负责在全基因组范围内的体外和离体成骨细胞向骨细胞的转变。目标二:检查和对比Wnt信号通路对成骨细胞和成熟骨细胞特异性基因表达模式的影响,并评估这些基因亚群在体外和离体直接受b-连环蛋白调节并受PTH和1,25(OH)2D 3影响的分子机制。我们的初步数据和其他人的数据表明,一些基因在骨细胞转化过程中上调,包括Sost,Fgf 23,Tnfsf 11和Enpp 1/3。然而,编码Wnt途径拮抗剂硬化蛋白(SCL)的Sost基因是最重要的,这是由于其对骨形成的中心生物学作用、其在疾病中的影响以及其作为潜在治疗靶点的相关性。在理解Sost调控方面已经取得了进展,部分是由于发现下游Sost增强子的缺失改变了Sost表达并导致了货车Buchem病。然而,我们的初步数据表明,显着的额外复杂性,从而支持本提案的最终目标。目标三:在体外和体内模型中,在表观基因组和调节组水平上评估Sost的基础和调节骨细胞表达的分子机制。骨细胞在骨骼中发挥独特的作用,并以内分泌方式发挥作用,以阐述局部旁分泌因子如硬化素和全身活性激素如FGF 23。异常骨细胞功能引起的病理后果可能是灾难性的。从拟议的研究中产生的详细的基本见解可能为多种疾病提供新的治疗干预途径 会影响骨骼

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J WESLEY PIKE其他文献

J WESLEY PIKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J WESLEY PIKE', 18)}}的其他基金

Transcriptional Control of Mouse FGF23 Expression in Health and Disease
健康和疾病中小鼠 FGF23 表达的转录控制
  • 批准号:
    9904622
  • 财政年份:
    2019
  • 资助金额:
    $ 34万
  • 项目类别:
Regulatory Mechanisms of Renal Vitamin D Activation and Degradation
肾脏维生素 D 激活和降解的调节机制
  • 批准号:
    9888365
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
Regulatory Mechanisms of Renal Vitamin D Activation and Degradation
肾脏维生素 D 激活和降解的调节机制
  • 批准号:
    10373006
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
Integrative genomics to define osteocyte differentiation, regulation and function
综合基因组学定义骨细胞分化、调节和功能
  • 批准号:
    8691297
  • 财政年份:
    2014
  • 资助金额:
    $ 34万
  • 项目类别:
Molecular Mechanisms of RANKL Activation in Osteoblasts
成骨细胞中 RANKL 激活的分子机制
  • 批准号:
    7989031
  • 财政年份:
    2009
  • 资助金额:
    $ 34万
  • 项目类别:
Vitamin D Ligands and Regulation of Calcium Homeostasis
维生素 D 配体和钙稳态调节
  • 批准号:
    7461164
  • 财政年份:
    2008
  • 资助金额:
    $ 34万
  • 项目类别:
Vitamin D Ligands and Regulation of Calcium Homeostasis
维生素 D 配体和钙稳态调节
  • 批准号:
    7591143
  • 财政年份:
    2008
  • 资助金额:
    $ 34万
  • 项目类别:
Vitamin D Ligands and Regulation of Calcium Homeostasis
维生素 D 配体和钙稳态调节
  • 批准号:
    8054311
  • 财政年份:
    2008
  • 资助金额:
    $ 34万
  • 项目类别:
Vitamin D Ligands and Regulation of Calcium Homeostasis
维生素 D 配体和钙稳态调节
  • 批准号:
    8237042
  • 财政年份:
    2008
  • 资助金额:
    $ 34万
  • 项目类别:
Molecular Mechanisms of Rankl Activation In Osteoblasts
成骨细胞Rankl激活的分子机制
  • 批准号:
    8536514
  • 财政年份:
    2007
  • 资助金额:
    $ 34万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
  • 批准号:
    2419915
  • 财政年份:
    2024
  • 资助金额:
    $ 34万
  • 项目类别:
    Standard Grant
Modelling drug binding to biological ion channels
模拟药物与生物离子通道的结合
  • 批准号:
    2747257
  • 财政年份:
    2022
  • 资助金额:
    $ 34万
  • 项目类别:
    Studentship
Elucidation of biological functions of the NCBP3 RNA-binding protein using a novel mutant mouse strain
使用新型突变小鼠品系阐明 NCBP3 RNA 结合蛋白的生物学功能
  • 批准号:
    22K06065
  • 财政年份:
    2022
  • 资助金额:
    $ 34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
  • 批准号:
    BB/V019848/1
  • 财政年份:
    2021
  • 资助金额:
    $ 34万
  • 项目类别:
    Research Grant
Structure and function of pufferfish toxin, tetrodotoxin, binding proteins as biological defense agent
河豚毒素、河豚毒素、结合蛋白作为生物防御剂的结构和功能
  • 批准号:
    19K06241
  • 财政年份:
    2019
  • 资助金额:
    $ 34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating a biological specificity conundrum: the role of dynamics in transcription factor binding
研究生物特异性难题:动力学在转录因子结合中的作用
  • 批准号:
    406750
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
    Studentship Programs
The molecular and biological roles of growth inhibiting chromatin binding proteins
生长抑制染色质结合蛋白的分子和生物学作用
  • 批准号:
    nhmrc : GNT1143612
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
    Project Grants
Electrical Detection of Small Molecule Binding to Biological Receptors using Organic Thin Film Transistors : A new approach for label free assays
使用有机薄膜晶体管对小分子与生物受体结合的电检测:一种无标记测定的新方法
  • 批准号:
    133593
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
    Feasibility Studies
Biological effect and preventive method for human serum albumin binding to transboundary air borne PM2.5.
人血清白蛋白与跨境空气PM2.5结合的生物学效应及预防方法。
  • 批准号:
    18H03039
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The molecular and biological roles of growth inhibiting chromatin binding proteins
生长抑制染色质结合蛋白的分子和生物学作用
  • 批准号:
    nhmrc : 1143612
  • 财政年份:
    2018
  • 资助金额:
    $ 34万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了